CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis-Reference-Cited by-同舟云学术

CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis

Published:2020-08-13 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Hisert Katherine B.,Birkland Timothy P.,Schoenfelt Kelly Q.,Long Matthew E.,Grogan Brenda,Carter Suzanne,Liles W. Conrad,McKone Edward F.,Becker Lev,Manicone Anne M.,Gharib Sina A.

Funder

Vertex Pharmaceuticals

National Heart, Lung, and Blood Institute

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference75 articles.

1. HTSeq–a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015

2. Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa;Barnaby;Am. J. Physiol. Lung Cell. Mol. Physiol.,2018

3. Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection;Bonfield;J. Leukocyte Biol.,2012

4. Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor;Bratcher;J. Cystic Fibrosis,2016

5. Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis;Brennan;Eur. Respiratory J.,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene expression responses of CF airway epithelial cells exposed to elexacaftor/tezacaftor/ivacaftor (ETI) suggest benefits beyond improved CFTR channel function;2024-08-29

2. Immune Response and Exhaled Breath Profile Changes after Initiation of CFTR Modulator Therapy in Children with CF;International Journal of Translational Medicine;2024-08-27

3. Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies;Genes;2023-10-20

4. Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators;International Journal of Molecular Sciences;2023-08-29

5. Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages;Scientific Reports;2023-07-25